The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Fickian and non-Fickian drug release from polymers.
Peppas, N. A. (1985) · PubMed · Cited by 2,139
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., & Speiser, P. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13510.x · Cited by 452
PLA/PLGA nanoparticles for sustained release of docetaxel
Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., & Puglisi, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.023 · Cited by 435
Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content
Budhian, A., Siegel, S. J., & Winey, K. I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.061 · Cited by 431
Feng, S.-S., & Huang, G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00364-3 · Cited by 398
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
Lu, W., Zhang, Y., Tan, Y.-Z., Hu, K.-L., Jiang, X.-G., & Fu, S.-K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.027 · Cited by 311
Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950474+ · Cited by 302
Hydrogen Bonding Interaction of Poly(d,l-Lactide)/hydroxyapatite Nanocomposites
Zhou, S., Zheng, X., Yu, X., Wang, J., Weng, J., Li, X., Feng, B., & Yin, M. (2007) · Chemistry of Materials · doi:10.1021/cm0619398 · Cited by 292
Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery
Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 260
Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242
Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235
Self-citationDelivery of125I-NGF to the Brain via the Olfactory Route
Frey, W. H., Liu, J., Chen, X., Thorne, R. G., Fawcett, J. R., Ala, T. A., & Rahman, Y.-E. (1997) · Drug Delivery · doi:10.3109/10717549709051878 · Cited by 210
Quantifying drug release from PLGA nanoparticulates
Corrigan, O. I., & Li, X. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.004 · Cited by 195
Lecithin Organogel as Matrix for Transdermal Transport of Drugs
Willimann, H., Walde, P., Luisi, P. L., Gazzaniga, A., & Stroppolo, F. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810906 · Cited by 163
Thermoanalysis of microspheres
Dubernet, C. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01947-f · Cited by 150
Rauser, L., Savage, J. E., Meltzer, H. Y., & Roth, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29304-6 · Cited by 144
el ela, A. A., Härtter, S., Schmitt, U., Hiemke, C., Spahn-Langguth, H., & Langguth, P. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357043969 · Cited by 143
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats
Dufès, C., Olivier, J., Gaillard, F. P., Gaillard, A., Couet, W. R., & Jm, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00039-5 · Cited by 141
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation
Muthu, M. S., Rawat, M. K., Mishra, A., & Singh, S. K. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.12.003 · Cited by 136
Wang, F., Jiang, X., & Lu, W. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00341-7 · Cited by 120
Shah, N., Chaudhari, K., Dantuluri, P., Murthy, R. S. R., & Das, S. (2009) · Journal of drug targeting · doi:10.1080/10611860903046628 · Cited by 114
The Cognitive Efficacy of Atypical Antipsychotics in Schizophrenia
Sharma, T., & Mockler, D. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199804001-00004 · Cited by 111
Ricci, M., Blasi, P., Giovagnoli, S., Rossi, C. R., Macchiarulo, G., Luca, G., Basta, G., & Calafiore, R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.023 · Cited by 105
Westin, U., Piras, E., Jansson, B., Bergström, U., Dahlin, M., Brittebo, E. B., & Björk, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.009 · Cited by 96
The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats
Zhang, Q., Zha, L., Zhang, Y., Jiang, W.-M., Lü, W., Shi, Z., Jiang, X., & Fu, S. (2006) · Journal of drug targeting · doi:10.1080/10611860600721051 · Cited by 89
Patil, S. B., & Sawant, K. K. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802456726 · Cited by 87
Self-citationPreparation of poly( DL ‐lactide‐co‐glycolide) nanoparticles without surfactant
Jeong, Y., Cho, C., Kim, S., Ko, K., Kim, S., Shim, Y., & Nah, J. (2001) · Journal of Applied Polymer Science · doi:10.1002/app.1326 · Cited by 87
Tafaghodi, M., Tabassi, S. A. S., Jaafari, M. R., Zakavi, S. R., & Momen-nejad, M. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.009 · Cited by 81
Praziquantel-loaded PLGA nanoparticles: preparation and characterization
Mainardes, R. M., & Evangelista, R. C. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026285 · Cited by 75
Khan, M. S., Patil, K., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.05.0017 · Cited by 62
Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz, E. L., Franklin, R. B., Gillespie, T. A., Murphy, A., BERNSTEIN, J. R., Chiu, A., Hotten, T. M., & Kassahun, K. (1997) · PubMed · Cited by 52
Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system
Krauland, A. H., & Bernkop‐Schnürch, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.011 · Cited by 49
Stability and In Vitro Drug Release of Flurbiprofen-Loaded Poly-ε-Caprolactone Nanospheres
Lacoulonche, F., Gamisans, F., Chauvet, A., García, M. L., Espina, M., & Egea, M. A. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102261 · Cited by 40
[Toxicity of drugs on nasal mucocilia and the method of its evaluation].
Xg, J., Jb, C., Xl, F., et al. (1995) · PubMed · Cited by 35
Han, M. (2000) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(20000103)75:1<60::aid-app7>3.0.co;2-8 · Cited by 15
Nanda, B., & Murthy, R. S. R. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.004 · Cited by 13
Nanocarrier Aided Nasal Vaccination: An Experimental and Computational Approach
Kammona, O., Alexopoulos, A. H., Karakosta, P., Kotti, K., Karageorgiou, V., & Kiparissides, C. A. (2010) · Industrial & Engineering Chemistry Research · doi:10.1021/ie100307t · Cited by 9
Cited by
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 306
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.030 · Cited by 289
Metadata
- Authors
- Seju, U., Kumar, A., & Sawant, K. K.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 7
- Issue
- 12
- Pages
- 4169-4176
- ISSN
- 1742-7061 (ISSN-L)
- OpenAlex
- W1988652094
- Cited by
- 365
- References
- 45
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.